http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101062670-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate | 2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101062670-B1 |
| titleOfInvention | Composition for the prevention or treatment of obesity-related diseases mediated by the activation of AMPK containing 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan as an active ingredient |
| abstract | The present invention provides a 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan-based compound for activating AMP-activated protein kinase (AMPK) derived from nutmeg and comprising the same as an active ingredient. The present invention relates to a composition for preventing and treating metabolic syndrome, such as obesity, and more specifically, obtained by extracting nutmeg with 30% or less ethanol aqueous solution and separating and purifying purely using chromatography. AMPK activating compound comprising any one of, 5-bis-aryl-3,4-dimethyltetrahydrofuran lignan-based compounds and AMPK enzymes such as obesity, diabetes, hyperlipidemia, cardiovascular diseases, etc. The present invention relates to a composition for preventing and treating metabolic syndrome-related diseases.n n n n Nutmeg, AMPK, 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans, obesity, metabolic syndrome |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190090539-A |
| priorityDate | 2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.